» Articles » PMID: 7642600

Induction of the Acyl-coenzyme A Synthetase Gene by Fibrates and Fatty Acids is Mediated by a Peroxisome Proliferator Response Element in the C Promoter

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Aug 18
PMID 7642600
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

The long-chain acyl-coenzyme A synthetase (ACS) gene gives rise to three transcripts containing different first exons preceded by specific regulatory regions A, B, and C. Exon-specific oligonucleotide hybridization indicated that only A-ACS mRNA is expressed in rat liver. Fibrate administration induced liver C-ACS strongly and A-ACS mRNA to a lesser extent. B-ACS mRNA remained undetectable. In primary rat hepatocytes and Fa-32 hepatoma cells C-ACS mRNA increased after treatment with fenofibric acid, alpha-bromopalmitate, tetradecylthioacetic acid, or alpha-linolenic acid. Nuclear run-on experiments indicated that fenofibric acid and alpha-bromopalmitate act at the transcriptional level. Transient transfections showed a 3.4-, 2.3-, and 2.2-fold induction of C-ACS promoter activity after fenofibric acid, alpha-bromopalmitate, and tetradecylthioacetic acid, respectively. Unilateral deletion and site-directed mutagenesis identified a peroxisome proliferator activator receptor (PPAR)-responsive element (PPRE) mediating the responsiveness to fibrates and fatty acids. This ACS PPRE contains three imperfect half sites spaced by 1 and 3 oligonucleotides and binds PPAR.retinoid X receptor heterodimers in gel retardation assays. In conclusion, the regulation of C-ACS mRNA expression by fibrates and fatty acids is mediated by PPAR.retinoid X receptor heterodimers interacting through a PPRE in the C-ACS promoters. PPAR therefore occupies a key position in the transcriptional control of a pivotal enzyme controlling the channeling of fatty acids into various metabolic pathways.

Citing Articles

PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.

Hayes C, Gallucci G, Boyer J, Assis D, Ghonem N Hepatol Commun. 2024; 9(1).

PMID: 39699308 PMC: 11661771. DOI: 10.1097/HC9.0000000000000612.


PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases.

Gallucci G, Hayes C, Boyer J, Barbier O, Assis D, Ghonem N Cells. 2024; 13(15.

PMID: 39120326 PMC: 11312002. DOI: 10.3390/cells13151296.


Present and Future of Dyslipidaemia Treatment-A Review.

Mercep I, Vujevic A, Strikic D, Radman I, Pecin I, Reiner Z J Clin Med. 2023; 12(18).

PMID: 37762780 PMC: 10531957. DOI: 10.3390/jcm12185839.


Insulin Regulation of Hepatic Lipid Homeostasis.

Uehara K, Santoleri D, Garcia Whitlock A, Titchenell P Compr Physiol. 2023; 13(3):4785-4809.

PMID: 37358513 PMC: 10760932. DOI: 10.1002/cphy.c220015.


Effects of tomato ketchup and tomato paste extract on hepatic lipid accumulation and adipogenesis.

Jeong J, Lee H, Park H, Yoon Y, Shin J, Jeong M Food Sci Biotechnol. 2023; 32(8):1111-1122.

PMID: 37215254 PMC: 10195947. DOI: 10.1007/s10068-023-01244-x.